Theravance Biopharma Inc (0TB.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 09:59PM CEST
| Previous close | 8.80 |
| Open | 8.80 |
| Bid | 8.55 x 0 |
| Ask | 8.60 x 0 |
| Day's range | 8.50 - 8.85 |
| 52-week range | 7.60 - 10.70 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates
Theravance's (TBPH) first-quarter 2024 earnings beat estimates while revenues meet the same.
- Zacks
Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates
Theravance Bio (TBPH) delivered earnings and revenue surprises of 52.63% and 0.25%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
Theravance Bio (TBPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
© 2024 Yahoo. All rights reserved.